In a type 1 diabetes (T1DM) mouse model, short term treatment with D-Ala2-GIP, prevented a reduction of bone formation parameters and at tissue level, it improved mechanical properties (36). This evidence concerns the gene GIP and type 1 diabetes mellitus.